MC, B., MT, F., A, R., F, S., J, M., PS, Z., . . . WS, W. (2023). Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma. Neuro-oncology, 25(11), 2058. https://doi.org/10.1093/neuonc/noad087
Chicago Style (17th ed.) CitationMC, Burger, et al. "Intracranial Injection of Natural Killer Cells Engineered with a HER2-targeted Chimeric Antigen Receptor in Patients with Recurrent Glioblastoma." Neuro-oncology 25, no. 11 (2023): 2058. https://doi.org/10.1093/neuonc/noad087.
MLA (9th ed.) CitationMC, Burger, et al. "Intracranial Injection of Natural Killer Cells Engineered with a HER2-targeted Chimeric Antigen Receptor in Patients with Recurrent Glioblastoma." Neuro-oncology, vol. 25, no. 11, 2023, p. 2058, https://doi.org/10.1093/neuonc/noad087.
